Amneal Pharmaceuticals Ownership 2024 | Who Owns Amneal Pharmaceuticals Now?
Institutional Ownership
45.12%
Insider Ownership
54.31%
Retail Ownership
0.57%
Institutional Holders
182.00
Amneal Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| UBS GROUP AG | 7.11% | 0.03% | 21,849,523 | 21,671,365 | 12164.13% | 138,744,471 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.55% | 0.00% | 13,994,178 | 265,945 | 1.94% | 88,863,030 | Jun 30, 2024 |
| TPG GP A, LLC | 4.01% | 1.79% | 12,328,767 | - | - | 78,287,670 | Jun 30, 2024 |
| BLACKROCK INC. | 3.67% | 0.00% | 11,282,430 | 2,118,258 | 23.11% | 71,643,429 | Jun 30, 2024 |
| RUBRIC CAPITAL MANAGEMENT LP | 3.49% | 1.79% | 10,721,778 | 1,179,830 | 12.36% | 68,083,290 | Jun 30, 2024 |
| FOSUN INTERNATIONAL LTD | 1.51% | 9.98% | 4,655,403 | -7,658,845 | -62.20% | 29,561,809 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 1.39% | 0.01% | 4,283,928 | 641,405 | 17.61% | 27,205,356 | Jun 30, 2024 |
| NEUBERGER BERMAN GROUP LLC | 1.16% | 0.02% | 3,568,353 | -352,622 | -8.99% | 22,659,041 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.11% | 0.00% | 3,408,535 | 635,485 | 22.92% | 21,647,858 | Jun 30, 2024 |
| STATE STREET CORP | 1.10% | 0.00% | 3,386,968 | 442,770 | 15.04% | 21,507,247,000 | Jun 30, 2024 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 0.87% | 1.00% | 2,669,943 | 50,000 | 1.91% | 16,954,138 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.82% | 0.00% | 2,531,369 | 573,162 | 29.27% | 16,074,193 | Jun 30, 2024 |
| BLACKBARN CAPITAL PARTNERS LP | 0.65% | 1.13% | 2,000,000 | 586,703 | 41.51% | 12,700,000 | Jun 30, 2024 |
| HENNESSY ADVISORS INC | 0.45% | 0.33% | 1,388,600 | 1,388,600 | 100.00% | 8,817,610 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.45% | 0.00% | 1,380,412 | 687,926 | 99.34% | 8,765,616 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 0.43% | 0.08% | 1,315,023 | 626,917 | 91.11% | 8,350,396 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.41% | 0.00% | 1,252,852 | -14,332 | -1.13% | 7,955,610,000 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.39% | 0.00% | 1,202,020 | -28,314 | -2.30% | 7,632,827 | Jun 30, 2024 |
| INVESCO LTD. | 0.38% | 0.00% | 1,178,379 | -67,436 | -5.41% | 7,482,707 | Jun 30, 2024 |
| TUCKER ASSET MANAGEMENT LLC | 0.36% | 1.54% | 1,111,064 | 1,111,064 | 100.00% | 7,055,256 | Jun 30, 2024 |
Amneal Pharmaceuticals's largest institutional shareholder is UBS GROUP AG, holding 7.11% of the company's total share outstanding, currently valued at $138.74M. The top 10 institutional shareholders own together 29.12% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FOSUN INTERNATIONAL LTD | 1.51% | 9.98% | 4,655,403 | -7,658,845 | -62.20% | 29,561,809 | Jun 30, 2024 |
| TPG GP A, LLC | 4.01% | 1.79% | 12,328,767 | - | - | 78,287,670 | Jun 30, 2024 |
| RUBRIC CAPITAL MANAGEMENT LP | 3.49% | 1.79% | 10,721,778 | 1,179,830 | 12.36% | 68,083,290 | Jun 30, 2024 |
| TUCKER ASSET MANAGEMENT LLC | 0.36% | 1.54% | 1,111,064 | 1,111,064 | 100.00% | 7,055,256 | Jun 30, 2024 |
| BLACKBARN CAPITAL PARTNERS LP | 0.65% | 1.13% | 2,000,000 | 586,703 | 41.51% | 12,700,000 | Jun 30, 2024 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 0.87% | 1.00% | 2,669,943 | 50,000 | 1.91% | 16,954,138 | Jun 30, 2024 |
| SANDERS MORRIS HARRIS LLC | 0.18% | 0.59% | 567,196 | 317,600 | 127.25% | 3,601,695 | Jun 30, 2024 |
| JACKSON CREEK INVESTMENT ADVISORS LLC | 0.05% | 0.38% | 161,760 | 161,760 | 100.00% | 1,027,000 | Jun 30, 2024 |
| HENNESSY ADVISORS INC | 0.45% | 0.33% | 1,388,600 | 1,388,600 | 100.00% | 8,817,610 | Jun 30, 2024 |
| SIGNATURE WEALTH MANAGEMENT PARTNERS, LLC | 0.02% | 0.32% | 66,666 | - | - | 423,329 | Jun 30, 2024 |
| TRANQUILLI FINANCIAL ADVISOR LLC | 0.02% | 0.31% | 71,414 | - | - | 458,478 | Jun 30, 2024 |
| CONVERGENCE INVESTMENT PARTNERS, LLC | 0.05% | 0.27% | 143,215 | 143,215 | 100.00% | 909,415 | Jun 30, 2024 |
| HUSSMAN STRATEGIC ADVISORS, INC. | 0.05% | 0.26% | 147,000 | 147,000 | 100.00% | 933,450 | Jun 30, 2024 |
| TEJARA CAPITAL LTD | 0.03% | 0.20% | 86,824 | 86,824 | 100.00% | 551,332 | Jun 30, 2024 |
| VIRTUS INVESTMENT ADVISERS, INC. | 0.01% | 0.19% | 34,510 | - | - | 219,139 | Jun 30, 2024 |
| NEBULA RESEARCH & DEVELOPMENT LLC | 0.04% | 0.12% | 119,284 | 22,501 | 23.25% | 757,453 | Jun 30, 2024 |
| EMC CAPITAL MANAGEMENT | 0.01% | 0.11% | 31,090 | - | - | 197,000 | Jun 30, 2024 |
| GLOBEFLEX CAPITAL L P | 0.05% | 0.10% | 149,035 | 14,666 | 10.91% | 946,372 | Jun 30, 2024 |
| ALGERT GLOBAL LLC | 0.15% | 0.10% | 452,724 | 46,537 | 11.46% | 2,875,000 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 0.43% | 0.08% | 1,315,023 | 626,917 | 91.11% | 8,350,396 | Jun 30, 2024 |
The largest Amneal Pharmaceuticals shareholder by % of total assets is FOSUN INTERNATIONAL LTD. The company owns 4.66M shares of Amneal Pharmaceuticals (AMRX), representing 9.98% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| UBS GROUP AG | 7.11% | 0.03% | 21,849,523 | 21,671,365 | 12164.13% | 138,744,471 | Jun 30, 2024 |
| BLACKROCK INC. | 3.67% | 0.00% | 11,282,430 | 2,118,258 | 23.11% | 71,643,429 | Jun 30, 2024 |
| HENNESSY ADVISORS INC | 0.45% | 0.33% | 1,388,600 | 1,388,600 | 100.00% | 8,817,610 | Jun 30, 2024 |
| RUBRIC CAPITAL MANAGEMENT LP | 3.49% | 1.79% | 10,721,778 | 1,179,830 | 12.36% | 68,083,290 | Jun 30, 2024 |
| TUCKER ASSET MANAGEMENT LLC | 0.36% | 1.54% | 1,111,064 | 1,111,064 | 100.00% | 7,055,256 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 0.26% | 0.02% | 811,853 | 710,598 | 701.79% | 5,148,000 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.45% | 0.00% | 1,380,412 | 687,926 | 99.34% | 8,765,616 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 1.39% | 0.01% | 4,283,928 | 641,405 | 17.61% | 27,205,356 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.11% | 0.00% | 3,408,535 | 635,485 | 22.92% | 21,647,858 | Jun 30, 2024 |
| FIRST TRUST ADVISORS LP | 0.20% | 0.00% | 629,244 | 629,244 | 100.00% | 3,995,699 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 0.43% | 0.08% | 1,315,023 | 626,917 | 91.11% | 8,350,396 | Jun 30, 2024 |
| BLACKBARN CAPITAL PARTNERS LP | 0.65% | 1.13% | 2,000,000 | 586,703 | 41.51% | 12,700,000 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.82% | 0.00% | 2,531,369 | 573,162 | 29.27% | 16,074,193 | Jun 30, 2024 |
| SEGALL BRYANT & HAMILL, LLC | 0.16% | 0.05% | 481,501 | 481,501 | 100.00% | 3,057,531 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.30% | 0.00% | 930,567 | 442,932 | 90.83% | 5,909,100 | Jun 30, 2024 |
| STATE STREET CORP | 1.10% | 0.00% | 3,386,968 | 442,770 | 15.04% | 21,507,247,000 | Jun 30, 2024 |
| PHOCAS FINANCIAL CORP. | 0.35% | 0.03% | 1,078,675 | 381,592 | 54.74% | 6,850,000 | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | 0.15% | 0.00% | 457,250 | 358,058 | 360.97% | 2,903,538 | Jun 30, 2024 |
| SANDERS MORRIS HARRIS LLC | 0.18% | 0.59% | 567,196 | 317,600 | 127.25% | 3,601,695 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.17% | 0.00% | 536,062 | 314,727 | 142.19% | 3,403,993 | Jun 30, 2024 |
As of Jun 30 2024, Amneal Pharmaceuticals's largest institutional buyer is UBS GROUP AG. The company purchased 21.67M stocks of AMRX, valued at $138.74M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FOSUN INTERNATIONAL LTD | 1.51% | 9.98% | 4,655,403 | -7,658,845 | -62.20% | 29,561,809 | Jun 30, 2024 |
| TEACHER RETIREMENT SYSTEM OF TEXAS | 0.01% | 0.00% | 27,106 | -720,284 | -96.37% | 172,000 | Jun 30, 2024 |
| HILLSDALE INVESTMENT MANAGEMENT INC. | - | - | - | -699,719 | -100.00% | - | Jun 30, 2024 |
| NEUBERGER BERMAN GROUP LLC | 1.16% | 0.02% | 3,568,353 | -352,622 | -8.99% | 22,659,041 | Jun 30, 2024 |
| VOYA INVESTMENT MANAGEMENT LLC | 0.02% | 0.00% | 53,477 | -326,942 | -85.94% | 339,579 | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 0.14% | 0.00% | 435,082 | -321,305 | -42.48% | 2,762,770 | Jun 30, 2024 |
| HSBC HOLDINGS PLC | 0.01% | 0.00% | 43,841 | -247,568 | -84.96% | 278,769 | Jun 30, 2024 |
| AXA S.A. | - | - | - | -239,333 | -100.00% | - | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -206,012 | -100.00% | - | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | 0.01% | 0.00% | 33,314 | -192,743 | -85.26% | 211,544 | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | 0.02% | 0.01% | 59,458 | -174,750 | -74.61% | 377,558 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.03% | 0.00% | 89,895 | -136,309 | -60.26% | 570,833 | Jun 30, 2024 |
| STRS OHIO | - | - | - | -108,500 | -100.00% | - | Jun 30, 2024 |
| CAXTON ASSOCIATES LP | - | - | - | -91,481 | -100.00% | - | Jun 30, 2024 |
| VICTORY CAPITAL MANAGEMENT INC | 0.02% | 0.00% | 62,515 | -90,568 | -59.16% | 396,970 | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | - | - | - | -78,098 | -100.00% | - | Jun 30, 2024 |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 0.02% | 0.00% | 55,951 | -73,201 | -56.68% | 355,288 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.01% | - | 33,401 | -70,889 | -67.97% | 212,000 | Jun 30, 2024 |
| INVESCO LTD. | 0.38% | 0.00% | 1,178,379 | -67,436 | -5.41% | 7,482,707 | Jun 30, 2024 |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | - | - | - | -64,584 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Amneal Pharmaceuticals's biggest institutional seller is FOSUN INTERNATIONAL LTD. The company sold -7.66M shares of AMRX, valued at $29.56M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| HENNESSY ADVISORS INC | 0.45% | 0.33% | 1,388,600 | 1,388,600 | 100.00% | 8,817,610 | Jun 30, 2024 |
| TUCKER ASSET MANAGEMENT LLC | 0.36% | 1.54% | 1,111,064 | 1,111,064 | 100.00% | 7,055,256 | Jun 30, 2024 |
| FIRST TRUST ADVISORS LP | 0.20% | 0.00% | 629,244 | 629,244 | 100.00% | 3,995,699 | Jun 30, 2024 |
| SEGALL BRYANT & HAMILL, LLC | 0.16% | 0.05% | 481,501 | 481,501 | 100.00% | 3,057,531 | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | 0.06% | 0.01% | 195,008 | 195,008 | 100.00% | 1,238,301 | Jun 30, 2024 |
| POLAR ASSET MANAGEMENT PARTNERS INC. | 0.06% | 0.02% | 176,600 | 176,600 | 100.00% | 1,121,410 | Jun 30, 2024 |
| JACKSON CREEK INVESTMENT ADVISORS LLC | 0.05% | 0.38% | 161,760 | 161,760 | 100.00% | 1,027,000 | Jun 30, 2024 |
| HUSSMAN STRATEGIC ADVISORS, INC. | 0.05% | 0.26% | 147,000 | 147,000 | 100.00% | 933,450 | Jun 30, 2024 |
| CONVERGENCE INVESTMENT PARTNERS, LLC | 0.05% | 0.27% | 143,215 | 143,215 | 100.00% | 909,415 | Jun 30, 2024 |
| CAPULA MANAGEMENT LTD | 0.04% | 0.01% | 125,732 | 125,732 | 100.00% | 798,398 | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.04% | 0.00% | 111,969 | 111,969 | 100.00% | 711,000 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.04% | 0.00% | 111,274 | 111,274 | 100.00% | 706,590 | Jun 30, 2024 |
| TEJARA CAPITAL LTD | 0.03% | 0.20% | 86,824 | 86,824 | 100.00% | 551,332 | Jun 30, 2024 |
| NORGES BANK | 0.03% | 0.00% | 86,200 | 86,200 | 100.00% | 547,370 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.03% | 0.00% | 85,609 | 85,609 | 100.00% | 543,617 | Jun 30, 2024 |
| CHARTWELL INVESTMENT PARTNERS, LLC | 0.02% | 0.02% | 67,933 | 67,933 | 100.00% | 432,000 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.02% | 0.00% | 61,826 | 61,826 | 100.00% | 392,595 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.02% | 0.00% | 52,017 | 52,017 | 100.00% | 330,308 | Jun 30, 2024 |
| BANK OF MONTREAL /CAN/ | 0.01% | 0.00% | 36,078 | 36,078 | 100.00% | 238,837 | Jun 30, 2024 |
| DYNAMIC TECHNOLOGY LAB PRIVATE LTD | 0.01% | 0.03% | 35,843 | 35,843 | 100.00% | 227,000 | Jun 30, 2024 |
| QUANTBOT TECHNOLOGIES LP | 0.01% | 0.01% | 29,662 | 29,662 | 100.00% | 188,354 | Jun 30, 2024 |
| OMERS ADMINISTRATION CORP | 0.01% | 0.00% | 27,200 | 27,200 | 100.00% | 172,720 | Jun 30, 2024 |
| INCEPTIONR LLC | 0.01% | 0.04% | 21,369 | 21,369 | 100.00% | 135,693 | Jun 30, 2024 |
| CORTON CAPITAL INC. | 0.01% | 0.06% | 19,051 | 19,051 | 100.00% | 120,974 | Jun 30, 2024 |
| HIGHTOWER ADVISORS, LLC | 0.00% | 0.00% | 13,203 | 13,203 | 100.00% | 82,000 | Jun 30, 2024 |
| JANNEY MONTGOMERY SCOTT LLC | 0.00% | 0.00% | 11,960 | 11,960 | 100.00% | 76,000 | Jun 30, 2024 |
| XPONANCE, INC. | 0.00% | 0.00% | 10,214 | 10,214 | 100.00% | 64,859 | Jun 30, 2024 |
| NVERSES CAPITAL, LLC | 0.00% | 0.04% | 9,800 | 9,800 | 100.00% | 62,230 | Jun 30, 2024 |
| DEKABANK DEUTSCHE GIROZENTRALE | 0.00% | 0.00% | 6,655 | 6,655 | 100.00% | 42,000 | Jun 30, 2024 |
| CANADA PENSION PLAN INVESTMENT BOARD | 0.00% | - | 3,000 | 3,000 | 100.00% | 19,050 | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | 0.00% | - | 2,103 | 2,103 | 100.00% | 13,000 | Jun 30, 2024 |
| OPTIVER HOLDING B.V. | 0.00% | - | 1,823 | 1,823 | 100.00% | 11,576 | Jun 30, 2024 |
| INNEALTA CAPITAL, LLC | 0.00% | 0.00% | 847 | 847 | 100.00% | 5,379 | Jun 30, 2024 |
| COMPASS WEALTH MANAGEMENT LLC | 0.00% | 0.00% | 200 | 200 | 100.00% | 1,270 | Jun 30, 2024 |
Amneal Pharmaceuticals's largest new institutional shareholder by number of shares is HENNESSY ADVISORS INC, purchased 1.39M shares, valued at $8.82M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| HILLSDALE INVESTMENT MANAGEMENT INC. | - | - | - | -699,719 | -100.00% | - | Jun 30, 2024 |
| AXA S.A. | - | - | - | -239,333 | -100.00% | - | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -206,012 | -100.00% | - | Jun 30, 2024 |
| STRS OHIO | - | - | - | -108,500 | -100.00% | - | Jun 30, 2024 |
| CAXTON ASSOCIATES LP | - | - | - | -91,481 | -100.00% | - | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | - | - | - | -78,098 | -100.00% | - | Jun 30, 2024 |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | - | - | - | -64,584 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -60,500 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -60,076 | -100.00% | - | Jun 30, 2024 |
| HEDGES ASSET MANAGEMENT LLC | - | - | - | -50,000 | -100.00% | - | Jun 30, 2024 |
| ENVESTNET ASSET MANAGEMENT INC | - | - | - | -41,050 | -100.00% | - | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | - | - | - | -30,995 | -100.00% | - | Jun 30, 2024 |
| KESTRA ADVISORY SERVICES, LLC | - | - | - | -30,250 | -100.00% | - | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | - | - | - | -28,123 | -100.00% | - | Jun 30, 2024 |
| GOTHAM ASSET MANAGEMENT, LLC | - | - | - | -25,322 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -20,112 | -100.00% | - | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | - | - | - | -12,817 | -100.00% | - | Jun 30, 2024 |
| SAVANT CAPITAL, LLC | - | - | - | -10,938 | -100.00% | - | Jun 30, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | - | - | - | -10,841 | -100.00% | - | Jun 30, 2024 |
| BAYESIAN CAPITAL MANAGEMENT, LP | - | - | - | -10,754 | -100.00% | - | Jun 30, 2024 |
| GLADIUS CAPITAL MANAGEMENT LP | - | - | - | -6,480 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -5,637 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -3,495 | -100.00% | - | Jun 30, 2024 |
| BARROW HANLEY MEWHINNEY & STRAUSS LLC | - | - | - | -1,576 | -100.00% | - | Jun 30, 2024 |
| CONCORD WEALTH PARTNERS | - | - | - | -600 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -396 | -100.00% | - | Jun 30, 2024 |
Amneal Pharmaceuticals's largest sold out institutional shareholder by shares sold is HILLSDALE INVESTMENT MANAGEMENT INC., sold -0.70M shares, valued at -, as of undefined.
Amneal Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| CORNERCAP GROUP OF FUNDS /VA/ | 1.19% | 85,996 | 85,996 | - | Sep 30, 2022 |
| Vanguard Montgomery Funds | 1.03% | 246,552 | - | - | Mar 31, 2024 |
| T. Rowe Price Mid-Cap Growth Fund, Inc. | 0.34% | 5,176,164 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL FUNDS | 0.31% | 245,860 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS VARIABLE SERIES I | 0.18% | 66,412 | - | - | Mar 31, 2024 |
| VANGUARD SPECIALIZED FUNDS | 0.17% | 9,306,210 | - | - | Jan 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.16% | 81,700 | - | - | Mar 31, 2024 |
| NEUBERGER BERMAN EQUITY FUNDS | 0.13% | 1,319,097 | -13,946 | -1.05% | Feb 29, 2024 |
| T. Rowe Price Equity Funds, Inc. | 0.11% | 1,242,280 | - | - | Mar 31, 2024 |
| SARATOGA ADVANTAGE TRUST | 0.11% | 6,737 | - | - | Feb 29, 2024 |
| Federated Hermes MDT Series | 0.10% | 249,033 | 178,332 | 252.23% | Jan 31, 2024 |
| Vericimetry Funds | 0.09% | 7,870 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS GLOBAL/INTERNATIONAL FUND, INC. | 0.08% | 175,157 | - | - | Mar 31, 2024 |
| T. Rowe Price Mid-Cap Value Fund, Inc. | 0.07% | 752,026 | - | - | Mar 31, 2024 |
| Voya EQUITY TRUST | 0.07% | 98,044 | 98,044 | - | Feb 29, 2024 |
| IndexIQ ETF Trust | 0.06% | 136,901 | - | - | Jan 31, 2024 |
| HUSSMAN INVESTMENT TRUST | 0.05% | 180,000 | - | - | Dec 31, 2023 |
| T. Rowe Price Equity Series, Inc. | 0.05% | 78,523 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.04% | 219,586 | - | - | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.04% | 83,200 | - | - | Mar 28, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.03% | 17,566 | -1,356 | -7.17% | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.03% | 11,640,813 | -1,529,601 | -11.61% | Mar 31, 2024 |
| AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC. | 0.03% | 61,324 | - | - | Mar 31, 2024 |
| VANGUARD EXPLORER FUND | 0.02% | 244,539 | - | - | Jan 31, 2024 |
| PFM Multi-Manager Series Trust | 0.02% | 16,148 | - | - | Dec 31, 2023 |
| AMG FUNDS III | 0.02% | 101,904 | - | - | Mar 28, 2024 |
| SSGA FUNDS | 0.02% | 7,519 | - | - | Feb 29, 2024 |
| SCHWAB CAPITAL TRUST | 0.02% | 678,431 | -99,352 | -12.77% | Jan 31, 2024 |
| Fidelity Commonwealth Trust II | 0.01% | 97,980 | 20,548 | 26.54% | Aug 31, 2023 |
| North Square Investments Trust | 0.01% | 134,380 | 13,600 | 11.26% | Feb 29, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 2,888 | - | - | Mar 31, 2024 |
| JNL VARIABLE FUND LLC | 0.01% | 69,802 | - | - | Mar 31, 2020 |
| Lattice Strategies Trust | 0.01% | 16,557 | 16,557 | - | Mar 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.01% | 24,047 | -24,687 | -50.66% | Feb 29, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.01% | 37,713 | - | - | Mar 31, 2024 |
| MML SERIES INVESTMENT FUND | 0.01% | 76,000 | - | - | Dec 31, 2023 |
| ADVISORS' INNER CIRCLE FUND | 0.01% | 191,000 | - | - | Jan 31, 2024 |
| Principal Exchange-Traded Funds | 0.01% | 95,992 | 61,045 | 174.68% | Mar 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.01% | 626,827 | 232,504 | 58.96% | Jan 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.01% | 182,489 | 133,544 | 272.85% | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.01% | 68,937 | 363 | 0.53% | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.01% | 1,116,724 | 216,203 | 24.01% | Feb 29, 2024 |
| TARGET PORTFOLIO TRUST | 0.01% | 105,800 | - | - | Jan 31, 2024 |
| GPS Funds I | 0.00% | 26,392 | -6,502 | -19.77% | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 12,022 | - | - | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 82,526 | -954 | -1.14% | Mar 31, 2024 |
| ALPS ETF Trust | 0.00% | 51,577 | - | - | Feb 29, 2024 |
| Managed Portfolio Series | 0.00% | 85,996 | - | - | Jan 31, 2024 |
| PRUDENTIAL INVESTMENT PORTFOLIOS, INC. | 0.00% | 29,900 | -1,400 | -4.47% | Mar 28, 2024 |
| STERLING CAPITAL FUNDS | 0.00% | 65,130 | - | - | Mar 28, 2024 |
| VANGUARD HORIZON FUNDS | 0.00% | 69,393 | -69,393 | -50.00% | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 84,839 | -6,717 | -7.34% | Mar 31, 2024 |
| MFS VARIABLE INSURANCE TRUST III | 0.00% | 45,021 | 28,136 | 166.63% | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 54,072 | 521 | 0.97% | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 1,023,180 | 608,328 | 146.64% | Jan 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 697,060 | 696,153 | 76753.36% | Feb 29, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 199,853 | 69,062 | 52.80% | Feb 29, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 34,482 | - | - | Mar 31, 2024 |
| HARTFORD SERIES FUND INC | 0.00% | 71,743 | - | - | Mar 31, 2024 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 369,986 | 14,028 | 3.94% | Feb 29, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 1,703,672 | - | - | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 818 | - | - | Apr 30, 2021 |
| VANGUARD WORLD FUND | 0.00% | 366,637 | 1,872 | 0.51% | Feb 29, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 429,619 | -103,839 | -19.47% | Jan 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 1,418,246 | 263,718 | 22.84% | Jan 31, 2024 |
| ProFunds | 0.00% | 15,536 | 2,618 | 20.27% | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 185,555 | -32,381 | -14.86% | Mar 28, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 116,385 | -2,073 | -1.75% | Feb 29, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 5,517 | -620 | -10.10% | Mar 31, 2024 |
| Victory Portfolios II | 0.00% | 57,271 | 54,828 | 2244.29% | Mar 31, 2024 |
| PUTNAM ASSET ALLOCATION FUNDS | 0.00% | 33,546 | - | - | Mar 31, 2024 |
| Virtus Investment Trust | 0.00% | 34,510 | -25,200 | -42.20% | Mar 28, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 554,534 | 6,713 | 1.23% | Feb 29, 2024 |
| FundVantage Trust | 0.00% | 14,100 | 13,038 | 1227.68% | Mar 28, 2024 |
| MAINSTAY VP FUNDS TRUST | 0.00% | 112,100 | - | - | Mar 31, 2024 |
| Voya INVESTORS TRUST | 0.00% | 48,792 | - | - | Mar 31, 2024 |
| Tidal ETF Trust | 0.00% | 11,176 | - | - | Jan 31, 2024 |
| VANGUARD QUANTITATIVE FUNDS | 0.00% | 3,996 | - | - | Mar 31, 2024 |
| Columbia Funds Variable Series Trust II | 0.00% | 26,300 | - | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 2,013 | - | - | Mar 31, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 22,048 | - | - | Mar 31, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 35,084 | - | - | Mar 31, 2024 |
| TRUST FOR PROFESSIONAL MANAGERS | 0.00% | 215,803 | 180,949 | 519.16% | Feb 29, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 43,390 | 2,800 | 6.90% | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 64,472 | 3,719 | 6.12% | Feb 29, 2024 |
| Federated Hermes Global Allocation Fund | 0.00% | 5,758 | -510 | -8.14% | Feb 29, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 236,175 | -38,190 | -13.92% | Feb 29, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 37,196 | - | - | Feb 29, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 59,735 | - | - | Mar 28, 2024 |
| JOHN HANCOCK INVESTMENT TRUST | 0.00% | 44,840 | - | - | Mar 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 67,244 | -15,400 | -18.63% | Mar 31, 2024 |
| GLENMEDE FUND INC | 0.00% | 4,365 | - | - | Jan 31, 2024 |
| SA FUNDS INVESTMENT TRUST | 0.00% | 7,273 | - | - | Mar 31, 2024 |
| FLEXSHARES TRUST | 0.00% | 35,339 | - | - | Jan 31, 2024 |
| PACE SELECT ADVISORS TRUST | 0.00% | 124,141 | - | - | Jan 31, 2024 |
| THRIVENT MUTUAL FUNDS | 0.00% | 35,441 | 17,988 | 103.07% | Jan 31, 2024 |
| LoCorr Investment Trust | 0.00% | 8,791 | - | - | Mar 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 26,782 | 16,465 | 159.59% | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 343,575 | -10,951 | -3.09% | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 4,587,241 | 32,235 | 0.71% | Mar 31, 2024 |
Amneal Pharmaceuticals's largest mutual fund holder by % of total assets is "CORNERCAP GROUP OF FUNDS /VA/", owning 86.00K shares, compromising 1.19% of its total assets.
Amneal Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 182 | 2.25% |
| 31 Mar, 24 | 178 | 16.34% |
| 31 Dec, 23 | 153 | 6.25% |
| 30 Sep, 23 | 144 | 12.50% |
| 30 Jun, 23 | 128 | -12.33% |
| 31 Mar, 23 | 146 | -7.59% |
| 31 Dec, 22 | 158 | 4.64% |
| 30 Sep, 22 | 151 | 1.34% |
| 30 Jun, 22 | 149 | -8.59% |
| 31 Mar, 22 | 163 | 5.84% |
| 31 Dec, 21 | 154 | -1.28% |
| 30 Sep, 21 | 156 | -1.27% |
| 30 Jun, 21 | 158 | -2.47% |
| 31 Mar, 21 | 162 | 21.80% |
| 31 Dec, 20 | 133 | -2.92% |
| 30 Sep, 20 | 137 | 0.74% |
| 30 Jun, 20 | 136 | 10.57% |
| 31 Mar, 20 | 123 | -1.60% |
| 31 Dec, 19 | 125 | 5.93% |
| 30 Sep, 19 | 118 | -7.09% |
| 30 Jun, 19 | 127 | -22.56% |
| 31 Mar, 19 | 164 | -2.38% |
| 31 Dec, 18 | 168 | -1.75% |
| 30 Sep, 18 | 171 | 2.40% |
| 30 Jun, 18 | 167 | - |
As of 30 Jun 24, 182 institutions are holding Amneal Pharmaceuticals's shares, representing an increase of 2.25% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 138,650,439 | 28.21% |
| 31 Mar, 24 | 108,142,002 | -0.95% |
| 31 Dec, 23 | 109,174,282 | 7.09% |
| 30 Sep, 23 | 101,946,076 | 4.62% |
| 30 Jun, 23 | 97,441,271 | 0.64% |
| 31 Mar, 23 | 96,825,813 | -4.95% |
| 31 Dec, 22 | 101,867,185 | 2.38% |
| 30 Sep, 22 | 99,497,073 | 0.07% |
| 30 Jun, 22 | 99,430,825 | -0.77% |
| 31 Mar, 22 | 100,201,165 | -0.53% |
| 31 Dec, 21 | 100,734,716 | 0.46% |
| 30 Sep, 21 | 100,277,070 | 0.42% |
| 30 Jun, 21 | 99,853,106 | -1.61% |
| 31 Mar, 21 | 101,487,728 | 2.01% |
| 31 Dec, 20 | 99,490,572 | -1.86% |
| 30 Sep, 20 | 101,374,877 | -0.21% |
| 30 Jun, 20 | 101,588,484 | 3.34% |
| 31 Mar, 20 | 98,306,335 | -2.96% |
| 31 Dec, 19 | 101,310,037 | -6.76% |
| 30 Sep, 19 | 108,651,368 | 2.13% |
| 30 Jun, 19 | 106,384,711 | -2.41% |
| 31 Mar, 19 | 109,012,210 | -6.16% |
| 31 Dec, 18 | 116,173,840 | 7.07% |
| 30 Sep, 18 | 108,503,244 | 11.35% |
| 30 Jun, 18 | 97,446,060 | - |
Amneal Pharmaceuticals (AMRX) has 138.65M shares outstanding as of 30 Jun 24, up 28.21% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 45.12% | 1.20% |
| 31 Mar, 24 | 61.40% | 1.23% |
| 31 Dec, 23 | 70.79% | 1.61% |
| 30 Sep, 23 | 66.31% | 1.62% |
| 30 Jun, 23 | 64.06% | 1.58% |
| 31 Mar, 23 | 63.66% | 1.41% |
| 31 Dec, 22 | 67.25% | 1.56% |
| 30 Sep, 22 | 65.72% | 1.52% |
| 30 Jun, 22 | 65.85% | 1.47% |
| 31 Mar, 22 | 66.85% | 1.47% |
| 31 Dec, 21 | 67.44% | 1.49% |
| 30 Sep, 21 | 67.17% | 1.50% |
| 30 Jun, 21 | 67.02% | 1.43% |
| 31 Mar, 21 | 68.57% | 1.51% |
| 31 Dec, 20 | 67.39% | 1.43% |
| 30 Sep, 20 | 68.70% | 1.45% |
| 30 Jun, 20 | 68.92% | 1.54% |
| 31 Mar, 20 | 66.79% | 1.31% |
| 31 Dec, 19 | 71.42% | 1.03% |
| 30 Sep, 19 | 83.11% | 1.20% |
| 30 Jun, 19 | 83.10% | 1.14% |
| 31 Mar, 19 | 85.37% | 1.03% |
| 31 Dec, 18 | 91.23% | 1.25% |
| 30 Sep, 18 | 85.27% | 1.45% |
| 30 Jun, 18 | 76.66% | - |
As of 30 Jun 24, Amneal Pharmaceuticals is held by 45.12% institutional shareholders, representing a 1.20% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 105 | 6.06% |
| 31 Mar, 24 | 99 | 16.47% |
| 31 Dec, 23 | 85 | -1.16% |
| 30 Sep, 23 | 86 | 48.28% |
| 30 Jun, 23 | 58 | 7.41% |
| 31 Mar, 23 | 54 | -33.33% |
| 31 Dec, 22 | 81 | 22.73% |
| 30 Sep, 22 | 66 | 8.20% |
| 30 Jun, 22 | 61 | -19.74% |
| 31 Mar, 22 | 76 | 22.58% |
| 31 Dec, 21 | 62 | - |
| 30 Sep, 21 | 62 | -18.42% |
| 30 Jun, 21 | 76 | -13.64% |
| 31 Mar, 21 | 88 | 51.72% |
| 31 Dec, 20 | 58 | 5.45% |
| 30 Sep, 20 | 55 | -14.06% |
| 30 Jun, 20 | 64 | -1.54% |
| 31 Mar, 20 | 65 | -16.67% |
| 31 Dec, 19 | 78 | 18.18% |
| 30 Sep, 19 | 66 | -1.49% |
| 30 Jun, 19 | 67 | -15.19% |
| 31 Mar, 19 | 79 | 14.49% |
| 31 Dec, 18 | 69 | -28.87% |
| 30 Sep, 18 | 97 | -41.57% |
| 30 Jun, 18 | 166 | - |
105 institutional shareholders have increased their position in AMRX stock as of 30 Jun 24 compared to 99 in the previous quarter (a 6.06% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 45 | - |
| 31 Mar, 24 | 45 | 2.27% |
| 31 Dec, 23 | 44 | 37.50% |
| 30 Sep, 23 | 32 | -11.11% |
| 30 Jun, 23 | 36 | -25.00% |
| 31 Mar, 23 | 48 | 11.63% |
| 31 Dec, 22 | 43 | -12.24% |
| 30 Sep, 22 | 49 | - |
| 30 Jun, 22 | 49 | -10.91% |
| 31 Mar, 22 | 55 | 1.85% |
| 31 Dec, 21 | 54 | 8.00% |
| 30 Sep, 21 | 50 | - |
| 30 Jun, 21 | 50 | 6.38% |
| 31 Mar, 21 | 47 | 6.82% |
| 31 Dec, 20 | 44 | -10.20% |
| 30 Sep, 20 | 49 | -2.00% |
| 30 Jun, 20 | 50 | 38.89% |
| 31 Mar, 20 | 36 | 20.00% |
| 31 Dec, 19 | 30 | - |
| 30 Sep, 19 | 30 | -18.92% |
| 30 Jun, 19 | 37 | -22.92% |
| 31 Mar, 19 | 48 | -30.43% |
| 31 Dec, 18 | 69 | 46.81% |
| 30 Sep, 18 | 47 | - |
| 30 Jun, 18 | - | - |
45 institutional shareholders have reduced their position in AMRX stock as of 30 Jun 24 compared to 45 in the previous quarter (a 0.00% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 182 | 2.25% | 138,650,439 | 28.21% | 45.12% | 1.20% | 105 | 6.06% | 45 | - |
| 31 Mar, 24 | 178 | 16.34% | 108,142,002 | -0.95% | 61.40% | 1.23% | 99 | 16.47% | 45 | 2.27% |
| 31 Dec, 23 | 153 | 6.25% | 109,174,282 | 7.09% | 70.79% | 1.61% | 85 | -1.16% | 44 | 37.50% |
| 30 Sep, 23 | 144 | 12.50% | 101,946,076 | 4.62% | 66.31% | 1.62% | 86 | 48.28% | 32 | -11.11% |
| 30 Jun, 23 | 128 | -12.33% | 97,441,271 | 0.64% | 64.06% | 1.58% | 58 | 7.41% | 36 | -25.00% |
| 31 Mar, 23 | 146 | -7.59% | 96,825,813 | -4.95% | 63.66% | 1.41% | 54 | -33.33% | 48 | 11.63% |
| 31 Dec, 22 | 158 | 4.64% | 101,867,185 | 2.38% | 67.25% | 1.56% | 81 | 22.73% | 43 | -12.24% |
| 30 Sep, 22 | 151 | 1.34% | 99,497,073 | 0.07% | 65.72% | 1.52% | 66 | 8.20% | 49 | - |
| 30 Jun, 22 | 149 | -8.59% | 99,430,825 | -0.77% | 65.85% | 1.47% | 61 | -19.74% | 49 | -10.91% |
| 31 Mar, 22 | 163 | 5.84% | 100,201,165 | -0.53% | 66.85% | 1.47% | 76 | 22.58% | 55 | 1.85% |
| 31 Dec, 21 | 154 | -1.28% | 100,734,716 | 0.46% | 67.44% | 1.49% | 62 | - | 54 | 8.00% |
| 30 Sep, 21 | 156 | -1.27% | 100,277,070 | 0.42% | 67.17% | 1.50% | 62 | -18.42% | 50 | - |
| 30 Jun, 21 | 158 | -2.47% | 99,853,106 | -1.61% | 67.02% | 1.43% | 76 | -13.64% | 50 | 6.38% |
| 31 Mar, 21 | 162 | 21.80% | 101,487,728 | 2.01% | 68.57% | 1.51% | 88 | 51.72% | 47 | 6.82% |
| 31 Dec, 20 | 133 | -2.92% | 99,490,572 | -1.86% | 67.39% | 1.43% | 58 | 5.45% | 44 | -10.20% |
| 30 Sep, 20 | 137 | 0.74% | 101,374,877 | -0.21% | 68.70% | 1.45% | 55 | -14.06% | 49 | -2.00% |
| 30 Jun, 20 | 136 | 10.57% | 101,588,484 | 3.34% | 68.92% | 1.54% | 64 | -1.54% | 50 | 38.89% |
| 31 Mar, 20 | 123 | -1.60% | 98,306,335 | -2.96% | 66.79% | 1.31% | 65 | -16.67% | 36 | 20.00% |
| 31 Dec, 19 | 125 | 5.93% | 101,310,037 | -6.76% | 71.42% | 1.03% | 78 | 18.18% | 30 | - |
| 30 Sep, 19 | 118 | -7.09% | 108,651,368 | 2.13% | 83.11% | 1.20% | 66 | -1.49% | 30 | -18.92% |
| 30 Jun, 19 | 127 | -22.56% | 106,384,711 | -2.41% | 83.10% | 1.14% | 67 | -15.19% | 37 | -22.92% |
| 31 Mar, 19 | 164 | -2.38% | 109,012,210 | -6.16% | 85.37% | 1.03% | 79 | 14.49% | 48 | -30.43% |
| 31 Dec, 18 | 168 | -1.75% | 116,173,840 | 7.07% | 91.23% | 1.25% | 69 | -28.87% | 69 | 46.81% |
| 30 Sep, 18 | 171 | 2.40% | 108,503,244 | 11.35% | 85.27% | 1.45% | 97 | -41.57% | 47 | - |
| 30 Jun, 18 | 167 | - | 97,446,060 | - | 76.66% | - | 166 | - | - | - |
Amneal Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Amneal Pharmaceuticals's stock was made by BOYER ANDREW S on Aug 16 2024, selling 22,486 shares at $7.81 per share (valued at $175.62K).
Amneal Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 3 | - |
| Q2 2024 | 18 | 11 | 163.64% |
| Q1 2024 | 27 | 29 | 93.10% |
| Q4 2023 | 5 | 5 | 100.00% |
| Q3 2023 | 1 | 2 | 50.00% |
| Q2 2023 | 18 | 10 | 180.00% |
| Q1 2023 | 22 | 21 | 104.76% |
| Q4 2022 | - | 1 | - |
| Q2 2022 | 19 | 14 | 135.71% |
| Q1 2022 | 10 | 12 | 83.33% |
| Q4 2021 | 2 | 1 | 200.00% |
| Q2 2021 | 19 | 14 | 135.71% |
| Q1 2021 | 9 | 10 | 90.00% |
| Q4 2020 | 3 | 3 | 100.00% |
| Q3 2020 | 3 | 1 | 300.00% |
| Q2 2020 | 17 | 9 | 188.89% |
| Q1 2020 | 14 | 8 | 175.00% |
| Q4 2019 | 13 | 8 | 162.50% |
| Q3 2019 | 5 | - | - |
| Q2 2019 | 26 | 16 | 162.50% |
0 total buy trades, and 3 total sell trades (buy/sell ratio of 0.00%) were made by Amneal Pharmaceuticals's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 3 | - |
| Q2 2024 | - | 2 | - |
| Q1 2024 | - | - | - |
| Q4 2023 | - | - | - |
| Q3 2023 | - | 1 | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | - | 1 | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | 1 | 1 | 100.00% |
| Q2 2021 | - | - | - |
| Q1 2021 | - | 1 | - |
| Q4 2020 | - | - | - |
| Q3 2020 | - | - | - |
| Q2 2020 | 2 | - | - |
| Q1 2020 | 4 | - | - |
| Q4 2019 | - | - | - |
| Q3 2019 | 3 | - | - |
| Q2 2019 | 2 | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 3 open market sell trades of Amneal Pharmaceuticals's stocks.
Amneal Pharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| ITCI | Intra-Cellular Therapies, Inc. |
| ANIP | ANI Pharmaceuticals, Inc. |
| LFCR | Lifecore Biomedical, Inc. |
| PAHC | Phibro Animal Health Corporation |
| DVAX | Dynavax Technologies Corporation |
| NBIX | Neurocrine Biosciences, Inc. |
| IRWD | Ironwood Pharmaceuticals, Inc. |
| ASRT | Assertio Holdings, Inc. |
| SSIC | Silver Spike Investment Corp. |
| ACRX | Talphera, Inc. |
| DCPH | Deciphera Pharmaceuticals, Inc. |
| PROC | Procaps Group S.A. |
| AGRX | Agile Therapeutics, Inc. |
| ALKS | Alkermes plc |
| COLL | Collegium Pharmaceutical, Inc. |
| EGRX | Eagle Pharmaceuticals, Inc. |
| EOLS | Evolus, Inc. |
| AMPH | Amphastar Pharmaceuticals, Inc. |
AMRX Ownership FAQ
Who Owns Amneal Pharmaceuticals?
Amneal Pharmaceuticals is owned by institutional shareholders (45.12%), insiders (54.31%), and public (0.57%). The largest institutional shareholder of Amneal Pharmaceuticals is UBS GROUP AG (7.11% of total shares) and the top mutual fund owner is CORNERCAP GROUP OF FUNDS /VA/ (1.19% of total shares).
Who are the major institutional shareholders of Amneal Pharmaceuticals?
Amneal Pharmaceuticals's major institutional shareholders are UBS GROUP AG, VANGUARD GROUP INC, TPG GP A, LLC, BLACKROCK INC., and RUBRIC CAPITAL MANAGEMENT LP. The top five shareholders own together 22.84% of the company's share outstanding.
How many Amneal Pharmaceuticals shareholders are there?
As of Jun 2024, there are 182 institutional shareholders of Amneal Pharmaceuticals.
What percentage of Amneal Pharmaceuticals is owned by UBS GROUP AG?
UBS GROUP AG owns 21.85M shares of Amneal Pharmaceuticals, representing 7.11% of the company's total shares outstanding, valued at $138.74M (as of Jun 2024).
What percentage of Amneal Pharmaceuticals is owned by VANGUARD GROUP INC?
As of Jun 2024, VANGUARD GROUP INC holds 13.99M shares of Amneal Pharmaceuticals (AMRX), compromising 4.55% of the company, valued at $88.86M.
What percentage of Amneal Pharmaceuticals is owned by TPG GP A, LLC?
TPG GP A, LLC is the third largest holder of Amneal Pharmaceuticals. The company owns 12.33M of the company's shares outstanding (worth $78.29M).